Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HCSG
HCSG logo

HCSG Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Healthcare Services Group Inc (HCSG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
19.320
1 Day change
0.78%
52 Week Range
22.980
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Healthcare Services Group Inc (HCSG) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance in the latest quarter and has positive analyst sentiment, the lack of immediate positive trading signals, insider selling, and the potential for short-term price declines suggest holding off on an investment for now.

Technical Analysis

The technical indicators show mixed signals. The MACD is positive but contracting, RSI is neutral at 39.777, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are at Pivot: 18.676, R1: 19.635, S1: 17.717. However, the stock trend analysis indicates a 70% chance of short-term price declines (-3.66% in the next day, -6.75% in the next week, -8.66% in the next month).

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios suggest a bullish sentiment in the options market, but the small volume and open interest make it less impactful for decision-making.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
6

Positive Catalysts

  • Strong financial performance in Q4 2025, with revenue up 6.59% YoY, net income up 162.11% YoY, and EPS up 175% YoY.

  • Positive analyst sentiment, with multiple price target increases and upgrades, including a $28 target from Benchmark.

  • Stable end-market trends and improving unit economics.

Neutral/Negative Catalysts

  • Significant insider selling, with a 964.46% increase in the last month.

  • Lack of recent news or event-driven catalysts.

  • Stock trend analysis indicates a high probability of short-term price declines.

  • No recent congress trading data to support the stock.

Financial Performance

In Q4 2025, Healthcare Services Group reported strong financial growth: revenue increased by 6.59% YoY to $466.68M, net income surged by 162.11% YoY to $31.24M, EPS grew by 175% YoY to 0.44, and gross margin improved to 15.44%, up 15.31% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is generally positive. RBC Capital initiated with a Sector Perform rating and a $22 price target, citing concerns about labor supply and valuation. William Blair upgraded the stock to Outperform, citing zero AI risk and strong end-market trends. Multiple firms raised price targets, including Benchmark ($28) and UBS ($25), reflecting optimism about the company's growth and earnings consistency.

Wall Street analysts forecast HCSG stock price to rise
4 Analyst Rating
Wall Street analysts forecast HCSG stock price to rise
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 19.170
sliders
Low
20
Averages
22
High
24
Current: 19.170
sliders
Low
20
Averages
22
High
24
RBC Capital
Ryan Halsted
Sector Perform
initiated
$22
AI Analysis
2026-03-03
Reason
RBC Capital
Ryan Halsted
Price Target
$22
AI Analysis
2026-03-03
initiated
Sector Perform
Reason
RBC Capital analyst Ryan Halsted initiated coverage of Healthcare Services with a Sector Perform rating and $22 price target. The company is benefitting from improving unit economics and payor policies around clinical quality is a potential driver of increased demand for outsourcing of its non-clinical services, the analyst tells investors in a research note. However, RBC cites its concerns around labor supply and the stock's valuation after the recent rally for the neutral rating.
William Blair
Market Perform
to
Outperform
upgrade
2026-02-20
Reason
William Blair
Price Target
2026-02-20
upgrade
Market Perform
to
Outperform
Reason
William Blair upgraded Healthcare Services to Outperform from Market Perform without a price target. The company's business model has "effectively zero AI risk," which is an increasingly attractive investment attribute in today's environment, the analyst tells investors in a research note. The firm believes Healthcare Services' end market trends are strong, with core skilled nursing facility clients experiencing higher occupancy rates, increasing demand for services, and a stable labor environment.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HCSG
Unlock Now

People Also Watch